Temple University is a public state-related research university in Philadelphia, Pennsylvania. It was founded in 1884 by the Baptist minister Russell Conwell and his congregation Grace Baptist Church of Philadelphia then called Baptist Temple. On May 12, 1888, it was renamed the Temple College of Philadelphia.

During the past decade, Temple University conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 47 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 28 clinical trials were completed. i.e. 48.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Temple University" #1 sponsor was "Temple University" with 52 trials, followed by "Brigham and Women's Hospital" with 5 trials sponsored, "Johns Hopkins University" with 5 trials sponsored, "University of Michigan" with 5 trials sponsored and "Emory University" with 5 trials sponsored. Other sponsors include 133 different institutions and companies that sponsored additional 116 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Temple University" #1 collaborator was "Temple University" with 31 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 24 trials as a collaborator, "University of Pennsylvania" with 9 trials as a collaborator, "Columbia University" with 8 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 8 trials as a collaborator. Other collaborators include 458 different institutions and companies that were collaborators in the rest 299 trials.

According to Clinical.Site data, the most researched conditions in "Temple University" are "Obesity" (12 trials), "Idiopathic Pulmonary Fibrosis" (8 trials), "Hypertension" (7 trials), "Heart Failure" (6 trials) and "Overweight" (6 trials). Many other conditions were trialed in "Temple University" in a lesser frequency.

Most popular intervention types in "Temple University" are "Drug" (82 trials), "Behavioral" (57 trials), "Device" (32 trials), "Other" (24 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Standard of Care" (3 trials), "CVRS Intervention" (2 trials), "FLX-787-ODT (orally disintegrating tablet)" (2 trials) and "Healthy Lifestyle Group" (2 trials). Other intervention names were less common.

The vast majority of trials in "Temple University" are 188 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 67 active trials in "Temple University". 1 are not yet recruiting, 48 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 110 completed trials in Temple University, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Temple University, 7 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 68 trials that are defined as “Not Applicable".

Temple University has several departments that took part in Clinical trials: "Temple University- Center for Obesity Research and Education" - 10 trials, "Center for Asian Health, Lewis Katz School of Medicine, Temple University" - 5 trials